GGrantIndex
Sort

21,453 grants matching tuberculosis

Structural characterization of the elongasome and divisome in mycobacteria

$492,000
James Chen · University Of California, San Francisco · DP2 · FY2025 · AI

The Role of Alcohol Use in Lung Disease After Treatment for Active TB Disease Among Persons Living with HIV

$491,872
Kaku So-Armah · Boston Medical Center · P01 · FY2024 · AA

Coping With HIV/AIDS in Tanzania

$491,853
Kathryn Whetten · Duke University · R01 · FY2011 · MH

Quantification of Circulating Antigens for Pediatric TB Diagnosis andTreatment Monitoring

$491,714
Tony Y. Hu · Arizona State University-Tempe Campus · R01 · FY2017 · AI

Optimal targeting for individual and population-level TB prevention

$491,559
Nicolas A Menzies · Harvard University D/B/A Harvard School Of Public Health · R01 · FY2024 · AI

US-Brazil Research Collaboration on Strain Variation in TB

$491,413
Jerrold J. Ellner · Univ Of Med/Dent Of Nj-Nj Medical School · U01 · FY2006 · AI

The role of Ser/Thr/Tyr phosphosignaling in the M. tuberculosis latency switch

$491,291
Christoph Grundner · Seattle Biomedical Research Institute · R01 · FY2016 · AI

Novel TB Treatment Strategy - Optimization of Macrophage Responsiveness to IFNy

$491,100
Igor Kramnik · Boston University Medical Campus · R33 · FY2015 · AI

Novel TB Treatment Strategy - Optimization of Macrophage Responsiveness to IFNy

$491,100
Igor Kramnik · Boston University Medical Campus · R33 · FY2017 · AI

Novel TB Treatment Strategy - Optimization of Macrophage Responsiveness to IFNy

$491,100
Igor Kramnik · Boston University Medical Campus · R33 · FY2016 · AI

Purine Analog Anti-Mycobacterial Drug Development

$491,096
Southern Research Institute · R01 · FY2005 · AI

An expert-guided machine-learning approach to estimate the incidence, risk and harms associated with diagnostic delays for infectious diseases.

$490,881
Philip M. Polgreen · University Of Iowa · R01 · FY2021 · HS

Clinical Core

$490,792
Daniel W Fitzgerald · Weill Medical Coll Of Cornell Univ · U19 · FY2024 · AI

CD4 T Cells in Tuberculosis

$490,643
Joanne L. Flynn · University Of Pittsburgh At Pittsburgh · R01 · FY2010 · AI

Structure/function studies of information flow in M. tuberculosis

$490,516
Thomas C Alber · Texas A&M Agrilife Research · P01 · FY2006 · AI

Developmental Core

$490,476
Joanne Turner · Texas Biomedical Research Institute · P30 · FY2023 · AI

University of Rochester Vaccine and Treatment Evaluation Unit (VTEU)

$490,470
Ann R Falsey · University Of Rochester · UM1 · FY2022 · AI

Characterization of the M. tuberculosis phagosome

$490,463
University Of California Los Angeles · R01 · FY2003 · HL

Active_Case_Finding_Testing_and_Linkage_to_Treatment_and_Improved_Survival_(ACTTIS)_Study

$490,414
Neil A Martinson · Wits Health Consortium (Pty), Ltd · R01 · FY2019 · AI

MACROMOLECULAR STRUCTURE DETERMINATION - GENERAL USERS

$490,344
Robert M Sweet · Brookhaven Science Assoc-Brookhaven Lab · P41 · FY2007 · RR

Structural Analysis of Metabolic Enzymes & Inhibitor Complexes in M. tubercul.

$490,116
James C Sacchettini · Texas A&M University · P01 · FY2012 · AI

TUBERCULOSIS TECHNOLOGY TRANSFER SUPPORT

$490,000
Claire Rodriges · · N01 · FY2007 · AI

Tulane National Primate Research Center

$489,860
Lee Hamm · Tulane University Of Louisiana · P51 · FY2018 · OD

Tracking CD4+ Memory T Cells in Vivo

$489,823
Marc K. Jenkins · University Of Minnesota · R01 · FY2022 · AI

MYCOBACTERIAL RESISTANCE TO REACTIVE NITROGEN/OXYGEN

$489,618
Weill Medical College Of Cornell Univ · R01 · FY2002 · HL